Related references
Note: Only part of the references are listed.Emerging Resistant Gram-Negative Aerobic Bacilli in Hospital-Acquired Infections
Anjali N. Kunz et al.
CHEMOTHERAPY (2010)
Treatment of Acinetobacter Infections
Joel Fishbain et al.
CLINICAL INFECTIOUS DISEASES (2010)
Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control
Y. Carmeli et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Emerging carbapenemases: a global perspective
Timothy R. Walsh
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Multidrug Resistant Acinetobacter
Vikas Manchanda et al.
JOURNAL OF GLOBAL INFECTIOUS DISEASES (2010)
Antimicrobial Susceptibility Testing: A Review of General Principles and Contemporary Practices
James H. Jorgensen et al.
CLINICAL INFECTIOUS DISEASES (2009)
In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii
Luigi Principe et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2009)
Tigecycline for the treatment of Acinetobacter infections:: A case series
Jason C. Gallagher et al.
ANNALS OF PHARMACOTHERAPY (2008)
Acinetobacter baumannii:: Emergence of a successful pathogen
Anton Y. Peleg et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
Increasing carbapenem resistance due to the clonal dissemination of oxacillinase (OXA-23 and OXA-58)-producing Acinetobacter baumannii: report from the Turkish SENTRY Program sites
Deniz Gur et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2008)
Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases
Marie-Francoise Tripodi et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Treatment of a septic shock due to multiresistant Acinetobacter baumannii with tigecycline in combination
T. Leclerc et al.
ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION (2007)
Global challenge of multidrug-resistant Acinetobacter baumannii
Federico Perez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro Pharmacokinetic/Pharmacodynamic model
Chun-Hong Tan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
High tigecycline resistance in multidrug-resistant Acinetobacter baumannii
Shiri Navon-Venezia et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40
Karen Lolans et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Tigecycline: First of a new class of antimicrobial agents
Warren E. Rose et al.
PHARMACOTHERAPY (2006)
Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline
F. S. Taccone et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2006)
Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis
G Orhan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Multi-resistant Gram-negative bacilli:: from epidemics to endemics
R Cantón et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2003)
In vitro investigation of the susceptibility of Acintetobacter baumannii strains isolated from clinical specimens to ampicillin/sulbactam alone and in combination with amikacin
E Savov et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2002)
The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida
N Safdar et al.
ANNALS OF INTERNAL MEDICINE (2002)
Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of Acinetobacter ventilator-associated pneumonia
GC Wood et al.
CLINICAL INFECTIOUS DISEASES (2002)
Nosocomial antibiotic resistance in multiple gram-negative species: Experience at one hospital with squeezing the resistance balloon at multiple sites
JJ Rahal et al.
CLINICAL INFECTIOUS DISEASES (2002)
Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem
AS Levin
CLINICAL MICROBIOLOGY AND INFECTION (2002)
In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak
MD Appleman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)